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INTRODUCTION
Oxygen therapy is a standard of care for cardiac patients.
Although being applied widely, surprisingly little is known
about the cellular effects of oxygen therapy, in particular, of
hyperoxia. The experimental studies performed more than a
decade ago introduced the concept of preconditioning-like
cardioprotection by hyperoxia (1). Pretreatment of animals with
hyperoxia improved recovery of postischemic contractile
function, reduced infarct size both in normal and atherosclerotic
hearts, reduced incidence of ischemia-reperfusion induced
arrhythmias and apoptotic cell death (2-6).
Despite of positive experimental results, translation of this
concept into clinical medicine has had several drawbacks. Two
subsequent trials on cardiac surgery patients did not show any
protective effects of hyperoxia, applied either for 130 or 60
minutes before cardiopulmonary bypass (7, 8). There are several
ways to explain these negative results. First, in case of modern
myocardial protection techniques only minimal myocardial
injury is caused by cardioplegic cardiac arrest, and there could
be no need for activation of intrinsic protective mechanisms.
Second, there is a possibility that the phenomenon of hyperoxia
induced myocardial protection does not exist in humans at all.
In animals, short exposure to normobaric or hyperbaric
oxygen induces changes in intracellular signalling, enzymes
acitivity and gene expression. In the rat brain, activities of
superoxide dismutase, catalase, glutathione peroxidase and
glutathione reductase are increased (9). In the rat heart,
hyperbaric oxygen enhances enzymatic activity and gene
expression of catalase, thereby significantly reducing the infarct
size after reperfusion (10). Achieved cardioprotection is related
to redox-sensitive transcription factor NFκB (11), tumor
necrosis factor receptor 1 - (12), opening of mitochondrial ATP-
sensitive potassium channels (13), and mitogen activated protein
kinases- and nitric oxide-dependant mechanisms (14). Most of
these protective mechanisms seem to be universal as they are
activated as a result of different conditioning stimuli (i.e classic
ischemic preconditioning, postconditioning as well as remote
ischemic preconditioning (15)). Whether all these changes occur
in humans, is not known.
Detection of diferent triggering or signalling molecules is
one possible approach to demonstrate adaptive changes induced
by hyperoxia. But to study cellular signalling is difficult in a
clinical setting - there always exists the possibility that some
pathways remain out of scope, and studies with receptor
antagonists or agonists are often not possible. Another approach
would be to evaluate changes in myocardial gene expression. In
particular, applying expression profile analysis on genome wide
level by RNAsequencing analysis would allow detection of all
possible changes related to hyperoxic pretreatment.
On that background, the present study was undertaken to
describe whether a short exposure to hyperoxia induces changes
in gene expression in the human myocardium, in patients with
coronary artery disease. We hypothesized that 60 min exposure
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In experimental setting the concept of myocardial preconditioning by hyperoxia has been introduced and different
intracellular protective mechanisms and their effects have been described. To study whether similar protective
phenotype can be induced by hyperoxia also in humans, gene expression profile after hyperoxic exposure was analyzed.
Adult patients were randomized to be ventilated with either FiO2 0.4 (n = 14) or 1.0 (n = 10) for 60 minutes before
coronary artery bypass grafting. A tissue sample from the right atrial appendage was taken for gene analysis and
expression profile analysis on genome wide level by RNA-seq analysis was applied. Exposure to > 96% oxygen for 60
minutes significantly changed the expression of 20 different genes, including upregulation of two different humanins -
MTRNR2L2 and MTRNR2L8, and activated a "cell survival" network as detected by Ingenuity Pathway Analyses. We
concluded that administration of > 96% oxygen for 1 hour changes gene expression in the myocardium of the patients
with coronary artery disease and may enhance cell survival capability.
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to hyperoxia is sufficient to induce overexpression of genes
related to possible adaptive cardioprotection.
MATERIALS AND METHODS
Patients
The study design was approved by the Ethics Review
Committee on Human Research of the University of Tartu. The
investigation conforms with the principles outlined in the
Declaration of Helsinki. Written informed consent was signed by
all patients before the study. The study was performed in the
departments of Cardiac Surgery of two tertiary care centres in
Estonia - Tartu University Hospital and North Estonia Medical
Centre. Adult patients scheduled for isolated primary elective
coronary artery bypass grafting with at least 3 distal anastomoses
were included and randomised into the control and hyperoxia
groups (Fig 1). The exclusion criteria were as follows: 1)
preoperative infusion of vasoactive or inotropic medications, 2)
diabetes mellitus treated either with insulin or oral medications,
3) preoperative elevated troponin T, and 4) pulmonary disease.
All medications, except salicylates were allowed until the
day of surgery.
Study protocol
After induction of anesthesia and intubation of the trachea,
patients were randomly allocated to receive either 40% or > 96%
oxygen for 60 minutes. The randomisation was performed by a
phone call to a randmisation centre where method of permuted
blocks was used. Thereafter the mixture of oxygen and air was
adjusted until the beginning of cardiopulmonary bypass (CPB)
to obtain arterial pO2 levels in the range of 100 – 150 mmHg.
The fraction of oxygen in inspired gas mixture was continuously
monitored by the gas analyser of the patient monitor. Arterial
blood gases were analysed (Radiometer ABL 700 series,
Radiometer Medical A/S, Copenhagen, Denmark) 10 and 60
minutes after randomisation. The patients were ventilated
according to the protocol until the cannulation for CPB during
which a tissue sample was harvested from the right atrial
appendage for gene analysis.
Standardized intravenous anesthesia with propofol, fentanyl
and midazolam was used. The patients were followed in the
intensive care unit for 48 postoperative hours.
Tissue samples and gene analysis
Myocardial tissue samples were immediately immersed in
RNALater, kept at +4°C and thereafter stored at –80°C for later
gene expression analysis.
For RNAextraction the tissue was homogenized using mortar
and liquid nitrogen. Total RNA was extracted from heart tissue
with the mirVana miRNAIsolation Kit (Thermo Fisher Scientific
Inc, Waltham, MA, USA) according to the manufacturers'
protocol. During the purification DNase I treatment was
performed on column according to manufacturers' protocol
(Qiagen Sciences, Germantown, MD, USA). The RNAquality
was assessed using A ilent 2100 Bioanalyzer and the RNA6000
Nano kit (Agilent Technologies Inc. CA, USA). The RIN (RNA
integrity number) for all samples was at least 7.45 ng of total
RNA. RNA was amplified with Ovation RNA-Seq System V2
Kit (NuGen, Emeryville, CA, USA) and the output double
stranded DNAwas used to prepare SOLiD 5500 W System DNA
fragment library according to manufacturers’protocols (Thermo
Fisher Scientific Inc, Waltham, MA, USA). The barcoding
primers in library preparation and fragment sequencing chemistry
was applied (75 bp in forward directions). In case of 12 samples
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Assessed for eligibility, n=202 
Excluded, n=174 
• Not meeting inclusion criteria, n=167 
• Declined to participate, n=2  
• Other reasons, n=5 
• Analysed, n=10 
• Excluded from analysis, n=2  
 Not analyzed due to laboratory logistics, 
n =2 
• Lost to follow-up (n=0) 
• Discontinued intervention (n=0) 
Allocated to intervention, ventilation with 
FiO2 100 %, n=12 
• Received allocated intervention, n=12 
• Did not receive allocated intervention, n=0 
• Lost to follow-up (n=0) 
• Discontinued intervention (n=0) 
Allocated to intervention, ventilation with 
FiO2 40 %, n=16 
• Received allocated intervention, n=16 
• Did not receive allocated intervention, n=0
• Analysed, n=14 
• Excluded from analysis, n=2  
 Sample damage during laboratory 
processing, n =1  








Fig. 1. Flow diagram of the
study.
per flowchip lane approximately 33 million mappable reads were
expected per one sample, which would be enough for successful
whole transcriptome expression pattern analysis.
Statistical analysis
Statistical analysis was performed in statistical environment R.
Non-normalized raw counts were used for the EdgeR package to
perform diferential gene expression analysis after quality control
of the samples. EdgeR performs model-based normalization,
estimates dispersions and applies modelling. EdgeR is very flexible
tool for RNAseq data analysis to find differentially expressed
genes (16, 17). We used groupwise comparison between two
treatment groups where negative binomial fitting was followed by
exact test for determining differential expression. False discovery
rate (FDR) adjustment was used for multiple testing correction
(18). The FDR threshold for statiscal signifcance was set to 0.1.
Patient data were compared with Fisher´s exact test or
Student t-test as appropriate.
Functional annotation of differentially expressed genes
The functional analysis of a gene network was used to identify
the biological functions that are most significantly related to the
molecules in the network. To define the functional networks of
differentially expressed genes, data were analyzed by using the
Ingenuity Pathway Analysis (IPA, Ingenuity Systems,
www.ingenuity.com) that calculates a significance score (network
score) for each network. This score indicates whether the
likelihood that the assembly of a set of focus genes in a network
could be explained by random chance alone (e.g., score of 2
indicates that there is a chance of 1 in 100 that the focus genes are
together in a network due to random chance). A data set containing
the gene identifiers and their corresponding fold change (log2)
values were uploaded into the IPA software. Each gene identifier
was mapped to its corresponding gene object in the Ingenuity
Pathways Knowledge Base to identify molecules whose expression
was significantly differentially regulated (focus genes or Networks
Eligible molecules). These focus genes were overlaid onto a global
molecular network developed from information contained in the
Ingenuity Knowledge Base. Networks of these focus genes were
then algorithmically generated based on their connectivity. A
network represents the molecular relationships between genes or
gene products, which are represented as nodes, and the biological
relationship between two nodes is represented as an edge line. All
edges are supported by at least one reference from the literature, or
from canonical information stored in the Ingenuity Pathways
Knowledge Base. Fold change difference threshold for the
functional analysis was set on 2 (log2 transformed).
RESULTS
Patient demographics and clinical data
Patients' characteristics are given in Table 1. There were no
inter-group diferences regarding preoperative medications and
operational data, but patients in the hyperoxia group were
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Variable Controls 
(n = 14) 
Hyperoxia 
pretreated 
(n = 10) 
P-value 
Age, years (min-max) 
Gender (male / female) 
Preoperative medications 
Ca-channel blockers, n  
Nitrates, n  
-blockers, n  
ACE-inhibitors, n  
Statins, n  
Preoperative ejection fraction, % 
paO2  10 min after intubation, mmHg 
paO2 60 min after intubation, mmHg 
Cross-clamping time, min 
Duration of cardiopulmonary bypass, min 
Number of vessels bypassed 
Need for inotropic support, n  
hsTnT 6h postoperatively, ng/mL 
hsTnT 1
st
 postoperative morning, ng/mL 
66.4 (56 – 73) 















59.8 (54 – 63) 
































Table 1. Characteristics of patients, oxygenation and surgical data.
slightly younger. Also, the clinical course in the postoperative
period as well as postoperative release of troponin T, decreased
values of which could be interpreted as decreased myocardial
damage after hyperoxic exposure, did not differ between groups.
Mean 'wash-out' time after 60 min exposure to > 96 % oxygen
until the collection of tissue samples was 51 (13 – 145) min.
Gene expression
The RNAdata can be found in GEO repository - GSE66249.
By genome wide chip analysis 23100 genes were identified in
the myocardial samples. Hyperoxic exposure caused significant
changes in expression of 20 genes (Figs. 2 and 3). Most
remarkable genes are two different humanins from the 10-
member humanin family - MTRNR2L2 and MTRNR2L8.
No significant diferences in gene expression between men
and women were found.
Ingenuity Pathway Analysis
To uncover potential regulatory network invoked during
hyperoxic treatment, network maps were constructed using
Ingenuity Pathway Analysis software. This helps to reveal
potential common patterns in the gene expression activation,
subject to regulation by the genes showing the highest
differential expression after pre-treatment with > 96% oxygen.
Gene network analysis allows to find and to identify functional
consequence of this activation. Two different approaches were
used. First, genes with the lowest FDR values (e.g. with the
highest statistical confidence) were analyzed. Functionally the
most relevant activated biochemical network was named 'cell
survival', where upregulation of ESCO2 and S100A8 was
evident (Fig. 3). As a second approach, we analyzed functional
impact of genes with the highest-fold changes. This analysis
indicated upregulation of several networks, from which the
network 'cell-to-cell signalling and interaction' was functionally
the most relevant (Figs. 4 and 5).
DISCUSSION
Exposure to > 96% oxygen for 60 minutes significantly
changes the expression of 20 different genes, including
upregulation of two different humanins in the heart of the
patients with coronary artery disease. This is the first time to
demonstrate that short-lasting breathing of hyperoxic gas
mixture enables significant cellular response in the human heart.
Upregulation of two different humanins from a 10-member
humanin family is of particular interest. Humanins, first
discovered in 2001 (19), are small anti-apoptotic peptides
originating from the human mitochondrial genome. By now, the
cytoprotective effect of humanins has been established in a
number of diferent stress situations, including oxidative stress
(20).
In the murine model, humanins ameliorate the eff cts of left
coronary occlusion. Pretreatment or treatment immediately
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Fig. 2. Genes with significant
changes in expression after pre-
treatment with hyperoxia.
Normalized counts of the 20
significantly changed gene
expression values are illustrated,
boxplots depict the different
study groups (black dots for
hyperoxia group, white dots for
controls). Genes are sorted
based on their FDR value.
MTRNR2L2 and MTRNR2L8
are humanin 2 and humanin 8.
Negative value of LogFC
indicates supression, positive
up-regulation of gene.
following the artery occlusion reduced infarct size and loss of
cardiac function, and decreased the apoptosis after myocardial
ischemia and reperfusion (21). Humanin also has a protective
effect on endothelial function, via modulating oxidative stress
and apoptosis in the developing atherosclerotic plaque (22).
Humanins are expressed also in the human vasculature, in
the endothelial cell layer of different blood vessels and in
atherosclerotic plaques (23, 24). Exogenous addition of humanin
analogue to endothelial cell cultures has shown to be effective
against Ox-LDL-induced oxidative stress (23). In patients
undergoing coronary angiography preserved coronary
endothelial function has been associated with higher systemic
humanin levels (25).
Interestingly, Ingenuity Pathway Analysis did not detected
involvement of humanins (MTRNR2L2 and MTRNR2L8) in any
of the cell survival networks (Figs. 4 and 5). This can be explained
by the limited amount of available information about the
humanins. On the other hand, ESCO2, the gene what was induced
by hyperoxia significantly and with high-fold change (2.8 times
induced), belongs to the cell survival network. NCRNA00240,
long non-coding RNAwith unknown function, was also induced
by hyperoxia 3.5 times compared to controls. This indicates, that
we found several genes without clear function, what makes
functional network analysis more difficult. However, induction of
survival related genes and network is relevant and expected.
Modification of gene expression seems promising, yet clinically
untested, approach in therapy of myocardial infarction (26).
Hyperoxia is known to be associated with excessive formation
of reactive oxygen species (ROS), especially after prolonged
exposure. Although ROS are commonly related to harmful or
physiological effects to the subcellular structures, the beneficial
effects of transient ROS formation by mediating the signalling of
adaptive defence reaction in mitochondria has been described as
well (27, 28). In human microvascular endothelial cells, hyperbaric
oxygen induced cytoprotective and angiogenic response against
oxidative insults (29), but the changes were minimal following
treatment with 100% O2 in the absence of elevated pressure (30).
Hyeroxia may also modify the response to different vasoactive
stimuli by enhancing vasodilatation in certain circumstances (31).
Similar to short hyperoxic exposure, which causes mild
oxidative stress and up-regulation of protective mechanisms (i.e.
induces 'readiness' to cope with massive oxidative burden upon
ischemia/reperfusion) exposure of H2O2-treated rat myoblasts to
nanomolar concentrations of humanin analogue induced
activation of catalase and glutathione peroxidase. Further, these
cells demonstrated preserved mitochondrial membrane
potential, ATP levels and mitochondrial structure, thus resulting
in rapid and sustained activation of critical cellular defence
systems and attenuation of oxidative stress (32). Similar
humanin-induced protection against oxidative stress has been
shown in rat retinal cultures (33).
Whether observed changes in the myocardial gene expression
after hyperoxic exposure are related to the possible adaption
against subsequent oxidative stress, remains speculative. Different
gene-expression profiling experiments have led to the discovery
of a protective genetic programme activated upon ischemic
preconditioning (IPC), and an injury genetic programme activated
in response to irreversible ischemic injury, whereas approximately
40% of the genes implicated in IPC are encoded mitochondrial
proteins, supporting the importance of mitochondria in IPC
mechanism of protection. Genes demonstrating changes in their
expression patterns are strongly dependent on the duration and
severity of the ischemic insult. All these studies exploring gene
expression following different preconditioning stimuli have been
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Fig. 3. Hierarchical clustering (heat
map) depicting expression profiles of
differentially regulated genes in the
cardiomyocytes of patients from
hyperoxia (red, 100) and control (green,
40) groups. Gene expression levels are
depicted as color variation from dark
blue (high expression) to pale green
(low expression). The color in each cel
of the figure displays the level of
expression for each gene (rows) of each
individual sample (columns).
recently extensively reviewed (34). In healthy volunteers, remote
IPC stimulus suppressed proinflammatory and upregulated anti-
inflammatory gene transcription in circulating leukocytes (35). In
patients, however, various comorbidities may confound with the
tissue response to cardiovascular diseases (36). Hyperoxic
preconditioning significantly improves the post-ischaemic
functional recovery of rat and mice hearts, reduces the infarct size,
and decreases necrotic damage as shown by the reduced release of
lactate dehydrogenase. Petrosillo et al. have postulated that in the
rat hearts inhibition of mitochondrial permeability transition pore
opening and cytochrome c release might by the underlying
mechanisms (37). Further, pretreatment with hyperoxia has been
shown to reduce apoptotic cell death induced by ischaemic insult
increased Bcl-2/Bax ratio (6). Both these aspects, reduced
cytochrome c release and reduced apoptosis are related to
cytoprotective effects of humanins, as it has been shown that
humanin peptides block Bax association with isolated
mitochondria, and suppress cytochrome c release in vitro (38).
The study has limitations. First, the patients in the hyperoxia
group appeared to be slightly younger. But this is inevitable in a
clinical study when age is not considered during randomization.
Most probably this minute difference does not result in different
gene expression in the human senescent heart, although
age-related differences in the murine hearts after a ischemic
preconditioning stimulus have been described (34). Second, the
interpretation of genomic expression data is complex, and to
determine whether these changes in response to potentially
injurious stimuli induce real adaptive/protective pathways, is
difficult at the moment. We cannot rule out all confounding factors
n our study, because the study group is small and quite rare.
However, this limitation is dificult to control in a clinical
intervention studies. This study is exploratory and further
xperiments to study detailed molecular mechanisms and
causality are needed. The results of present study should
encourage additional studies to analyze the real functional effect
and clinical utility of the intervention.
The present study demonstrates that a simple and widely used
therapeutic measure ( > 96% oxygen administration for 1 hour)
changes gene expression signature in the myocardium of patients
with coronary artery disease. Among others, two different
humanins were upregulated and survival related genes and
network were induced. We propose that upregulation of
humanins is a crucial event to afford cytoprotection in the heart
and potentially in any other tissue as gene expression was
induced in the tissue distant from lungs.
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Fig. 4. Network map illustrating
the activation of cell survival
network as a response to the
stimulation with hyperoxia. Red
colour depicts up-regulation of
the gene, green colour depicts
down-regulation of the gene.
Small bars by the symbol
indicate quantitative value F up-
or down-regulation.
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